TradeUP Acquisition (UPTD) Competitors

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Competitors Headlines Ownership Social Media

UPTD vs. GMDA, WINT, GMDAQ, ELOX, SQZ, ALBT, KRBP, NSTGQ, TCBP, and SCNI

Should you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include Gamida Cell (GMDA), Windtree Therapeutics (WINT), Gamida Cell (GMDAQ), Eloxx Pharmaceuticals (ELOX), SQZ Biotechnologies (SQZ), Avalon GloboCare (ALBT), Kiromic BioPharma (KRBP), NanoString Technologies (NSTGQ), TC Biopharm (TCBP), and Scinai Immunotherapeutics (SCNI). These companies are all part of the "biological products, except diagnostic" industry.

TradeUP Acquisition vs.

TradeUP Acquisition (NASDAQ:UPTD) and Gamida Cell (NASDAQ:GMDA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, community ranking, dividends and institutional ownership.

: Company Net Margins Return on Equity Return on Assets
TradeUP Acquisition N/A N/A -3.38%
Gamida Cell N/A N/A -57.59%
: TradeUP Acquisition has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, Gamida Cell has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500.
: TradeUP Acquisition has higher earnings, but lower revenue than Gamida Cell.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TradeUP Acquisition N/A N/A -$1M N/A N/A
Gamida Cell $1.78M 1.43 -$63M -$0.63 -0.03
: Gamida Cell received 112 more outperform votes than TradeUP Acquisition when rated by MarketBeat users.
Company Underperform Outperform
TradeUP Acquisition N/A N/A
Gamida Cell Outperform Votes
112
68.71%
Underperform Votes
51
31.29%
: Gamida Cell has a consensus price target of $4.75, indicating a potential upside of 28,514.46%. Given Gamida Cell's higher probable upside, analysts plainly believe Gamida Cell is more favorable than TradeUP Acquisition.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TradeUP Acquisition
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Gamida Cell
0 Sell rating(s)

1 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.75
: In the previous week, TradeUP Acquisition's average media sentiment score of 0.67 beat Gamida Cell's score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the media.
Company Overall Sentiment
TradeUP Acquisition Positive
Gamida Cell Neutral
: 35.0% of TradeUP Acquisition shares are held by institutional investors. Comparatively, 50.3% of Gamida Cell shares are held by institutional investors. 55.1% of TradeUP Acquisition shares are held by company insiders. Comparatively, 3.4% of Gamida Cell shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
TradeUP Acquisition	N/A	N/A	-3.38%
Gamida Cell	N/A	N/A	-57.59%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TradeUP Acquisition	N/A	N/A	-$1M	N/A	N/A
Gamida Cell	$1.78M	1.43	-$63M	-$0.63	-0.03

Company	Underperform	Outperform
TradeUP Acquisition	N/A	N/A
Gamida Cell	Outperform Votes 112 68.71%	Underperform Votes 51 31.29%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TradeUP Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Gamida Cell	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Company	Overall Sentiment
TradeUP Acquisition	Positive
Gamida Cell	Neutral

Summary

Gamida Cell beats TradeUP Acquisition on 6 of the 10 factors compared between the two stocks.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Get TradeUP Acquisition News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UPTD vs. The Competition

Export to Excel

Metric	TradeUP Acquisition	Biological Products Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.32M	$2.48B	$4.83B	$7.32B
Dividend Yield	N/A	2.83%	2.94%	4.01%
P/E Ratio	N/A	43.09	269.61	20.06
Price / Sales	N/A	363.62	2,447.95	89.03
Price / Cash	N/A	156.48	47.30	34.82
Price / Book	-0.67	3.63	4.55	4.16
Net Income	-$1M	-$49.27M	$104.05M	$214.20M

TradeUP Acquisition Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GMDA Gamida Cell	0.6028 of 5 stars	$0.01 +204.1%	$4.75 +31,779.2%	-99.0%	$2.30M	$1.78M	-0.02	143
WINT Windtree Therapeutics	0.2762 of 5 stars	$0.42 flat	N/A	-93.9%	$2.17M	N/A	-0.02	20	Stock Split News Coverage
GMDAQ Gamida Cell	0 of 5 stars	$0.02 flat	N/A	N/A	$2.62M	$1.78M	-0.03	N/A	Gap Down
ELOX Eloxx Pharmaceuticals	0.4579 of 5 stars	$0.99 +1.0%	$55.00 +5,470.3%	-89.1%	$3.10M	N/A	-0.11	18	Gap Up
SQZ SQZ Biotechnologies	0 of 5 stars	$0.05 flat	N/A	-99.3%	$1.37M	$18.16M	-0.02	53
ALBT Avalon GloboCare	0 of 5 stars	$0.31 +3.3%	N/A	-84.9%	$3.45M	$1.20M	0.00	5	Positive News Gap Up
KRBP Kiromic BioPharma	0 of 5 stars	$2.91 +3.6%	N/A	-32.5%	$3.75M	N/A	-0.19	35	Gap Up
NSTGQ NanoString Technologies	0 of 5 stars	$0.08 flat	N/A	N/A	$3.76M	$127.26M	-0.02	550	News Coverage Positive News Gap Down
TCBP TC Biopharm	0.4359 of 5 stars	$1.33 +1.5%	$1,400.00 +105,163.2%	-99.5%	$904,000.00	$4.76M	0.00	60	Positive News
SCNI Scinai Immunotherapeutics	0 of 5 stars	$0.48 +6.7%	N/A	N/A	$897,000.00	N/A	-0.15	33

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:UPTD) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

TradeUP Acquisition (UPTD) Competitors

UPTD vs. GMDA, WINT, GMDAQ, ELOX, SQZ, ALBT, KRBP, NSTGQ, TCBP, and SCNI

TradeUP Acquisition vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UPTD vs. The Competition

TradeUP Acquisition Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info